Pvg Asset Management Corp Windtree Therapeutics Inc Transaction History

Pvg Asset Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	BUY	$0.3 - $306.0 $56,118 - $57.2 Million	187,060 New	187,060 $0
Q3 2021 Nov 10, 2021	SELL	$1.66 - $2.27 $113,178 - $154,768	-68,180 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$1.68 - $2.79 $7,366 - $12,234	4,385 Added 6.87%	68,180 $156,000
Q1 2021 May 14, 2021	BUY	$2.14 - $6.18 $136,521 - $394,253	63,795 New	63,795 $156,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $9.49M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Pvg Asset Management Corp with notifications on news.